Roger C. Denton and Kristine K. Kraft, Partners at Schlichter, Bogard & Denton, LLP Law Firm, Selected as 2013 Super Lawyers®

Share Article

The Pharmaceuticals and Medical Litigation Department at Schlichter, Bogard & Denton, LLP is proud to announce that partners Roger C. Denton and Kristine K. Kraft have been selected as 2013 Super Lawyers®, which is a distinction given to attorneys who have attained a high-degree of peer recognition and professional achievement. The selection process involves independent research by Thomson Reuters, along with consideration of peer nominations and evaluations.

Roger C. Denton and Kristine K. Kraft, partners in the Pharmaceuticals and Medical Litigation Department at Schlichter, Bogard & Denton, LLP, have been selected as 2013 Super Lawyers®.

Schlichter, Bogard & Denton, LLP is a law firm with a national reputation for being a leader in complex litigation matters, including pharmaceutical and medical device cases.

Roger C. Denton and Kristine K. Kraft, partners in the Pharmaceuticals and Medical Litigation Department at Schlichter, Bogard & Denton, LLP, have been selected as 2013 Super Lawyers®. Schlichter, Bogard & Denton, LLP is a law firm with a national reputation for being a leader in complex litigation matters, including pharmaceutical and medical device cases. Our highest priority at Schlichter, Bogard & Denton, LLP is our commitment to practicing law to the highest standard of excellence in every phase of the trial process.

Roger C. Denton is a partner and the chair of the Pharmaceuticals and Medical Litigation Department at Schlichter, Bogard & Denton, LLP. Mr. Denton has devoted his legal career to representing individuals who have been seriously injured and has a national reputation as a leader in pharmaceutical litigation. He is acting as MDL Liaison Counsel in the Multidistrict Litigation In re Yasmin® and Yaz® (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL 2100, Case No. 09-md-2100), having been appointed by Chief Judge David Herndon of the Southern District of Illinois. Mr. Denton is also Co-Lead Counsel in several Multidistrict Litigations, including In re: NuvaRing® Products Liability Litigation (MDL 1964, Case No. 08-md-1964), having been appointed by Judge Rodney Sippel of the Eastern District of Missouri; In Re: E.I. Du Pont De Nemours and Company C-8 Personal Injury Litigation (MDL 2433, Case No. 13-md-2433), having been appointed by Judge Edmund Sargus of the Southern District of Ohio; and In re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation (MDL 2385, Case No. 12-md-2385), having been appointed by Chief Judge Herndon of the Southern District of Illinois. Mr. Denton has also served on the National Plaintiffs’ Steering Committees in the Multidistrict Litigation In re Ortho Evra® Products Liability Litigation (MDL 1742, Case No. 06-cv-40000), having been appointed by Judge David A. Katz of the Northern District of Ohio, as well as the Multidistrict Litigation In re Gadolinium-Based Contrast Agents Product Liability Litigation (MDL 1909, Case No. 08-gd-50000), having been appointed by Judge Dan A. Polster of the Northern District of Ohio.

Kristine K. Kraft is a partner at Schlichter, Bogard & Denton, LLP and has focused her practice on products liability cases involving dangerous pharmaceutical drugs and defective medical devices. Among other accomplishments, she has been appointed by The Honorable Judge Rodney Sippel of the United States District Court for the Eastern District of Missouri to serve in the managing roles of both Plaintiffs’ Liaison Counsel and Co-Lead Counsel in the Multidistrict Litigation In re: NuvaRing® Products Liability Litigation (MDL 1964, Case No. 08-md-1964). She also presently serves as Co-Chair for the Science Committee in the Multidistrict Litigation In re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation (MDL 2385, Case No. 12-md-2385). Ms. Kraft has also served on the Science and Discovery Committees for other Multidistrict Litigation cases, including In re Yasmin® and Yaz® (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL 2100, Case No. 09-md-2100); In re Ortho Evra® Products Liability Litigation (MDL 1742, Case No. 06-cv-40000); and In re Gadolinium-Based Contrast Agents Product Liability Litigation (MDL 1909, Case No. 08-gd-50000).

About Schlichter, Bogard & Denton, LLP
Schlichter, Bogard & Denton, LLP is a unique law firm that aggressively represents its clients injured as a result of dangerous pharmaceutical medications and unsafe medical devices. With hard work, creative thinking, and strong trial skills, we have earned an outstanding nationwide reputation by representing thousands of individuals who have suffered serious injuries. If you or a loved one has suffered injuries as a result of a dangerous pharmaceutical medication or unsafe medical device, please contact the attorneys at Schlichter, Bogard & Denton, LLP toll-free at 1-800-873-5297 for your confidential and free consultation.

The choice of a lawyer is an important decision and should not be based solely on advertisements. The cases discussed do not guarantee similar results and are not predictive of outcomes in future cases.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kristine K. Kraft
Schlichter Bogard & Denton, LLP
+1 (314) 621-6115
Email >
Visit website